| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |